Fordolac MR Tablet

Introduction

Fordolac MR is a medication that contains two active ingredients: Etodolac and Thiocolchicoside. It is available in tablet form and is commonly prescribed for the treatment of certain musculoskeletal disorders and associated pain.

Uses

Fordolac MR is primarily used to relieve pain and inflammation associated with conditions such as arthritis, sprains, strains, and muscle spasms. It can help reduce swelling and improve mobility, allowing patients to manage their symptoms more effectively.

Dosage and Administration

The dosage of Fordolac MR may vary depending on the severity of the condition and the individual patient. Follow the instructions provided by your healthcare professional. Typically, the recommended dosage is one tablet taken orally with water, usually after meals. It is important not to exceed the prescribed dose and to take the medication as directed.

Mechanism of Action

Etodolac, one of the active ingredients in Fordolac MR, belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by reducing the production of certain chemicals in the body that cause pain and inflammation. Thiocolchicoside, on the other hand, is a muscle relaxant that helps relieve muscle stiffness and spasms, providing additional relief to patients.

Side Effects

Common side effects may include upset stomach, nausea, indigestion, and dizziness. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as severe stomach pain, black stools, or difficulty breathing, seek medical attention immediately.

Drug Interactions

Fordolac MR may interact with certain medications, including blood-thinning drugs, diuretics, and other NSAIDs. Inform your healthcare professional about all the medications you are currently taking, including over-the-counter drugs and herbal supplements, to avoid any potential interactions. They can help determine if Fordolac MR is safe for you to use.

Precautions

Before taking Fordolac MR, inform your healthcare professional about any allergies you may have, especially to NSAIDs or other medications. Disclose any relevant medical conditions, such as a history of stomach ulcers, kidney or liver problems, or high blood pressure. Fordolac MR should be used with caution in certain patient populations, such as the elderly or those with a history of heart disease or stroke.

Storage

Fordolac MR should be stored in a cool, dry place, away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use Fordolac MR if the packaging is damaged or if the tablets have expired. Proper storage helps maintain the effectiveness and safety of the medication.

Patient Tips

Here are a few additional tips to help you make the most of your treatment with Fordolac MR:

• Take the medication as prescribed by your healthcare professional and do not exceed the recommended dose.
• If you experience any new or worsening symptoms while taking Fordolac MR, consult your healthcare professional.
• Avoid consuming alcohol while taking this medication, as it can increase the risk of stomach irritation and other side effects.
• If you are pregnant, planning to become pregnant, or breastfeeding, discuss the use of Fordolac MR with your healthcare professional, as it may not be suitable for use during these times.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Etopan XL 600 mg Film-coated prolonged release tablets (Health Professionals SmPC) Available at:
• Etodolac (Drugs.com) [Accessed 20 Jun. 2024] (online) Available at:
• etodolac (RX) [Accessed 25 Jun. 2024] (online) Available at:
• Etodolac (MedlinePlus) [Accessed 5 Jun. 2024] (online) Available at:
• [No authors listed] Etodolac. 2018 Apr 5. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. [Accessed 1 Jun. 2024] Available at: